Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: a single center study

Abstract Background Pulmonary exacerbations (PEx) are a major driver of morbidity and mortality in cystic fibrosis and reducing their frequency by extending the time between them is an important therapeutic goal. Although treatment decisions for exacerbations are often made based on dynamic changes...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Julia C. Espel, Hannah L. Palac, Joanne F. Cullina, Alexandria P. Clarke, Susanna A. McColley, Michelle H. Prickett, Manu Jain
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMC 2017-11-01
Seri Bilgileri:BMC Pulmonary Medicine
Konular:
Antibiotics
Bronchiectasis
Cystic fibrosis
Exacerbation
Outcomes Pseudomonas aeruginosa
Online Erişim:http://link.springer.com/article/10.1186/s12890-017-0503-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller